Comparison of the effects of twice-daily exenatide and insulin on carotid intima-media thickness in type 2 diabetes mellitus patients: a 52-week randomized, open-label, controlled trial
出版年份 2020 全文链接
标题
Comparison of the effects of twice-daily exenatide and insulin on carotid intima-media thickness in type 2 diabetes mellitus patients: a 52-week randomized, open-label, controlled trial
作者
关键词
-
出版物
Cardiovascular Diabetology
Volume 19, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-04-25
DOI
10.1186/s12933-020-01014-7
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Effects of Once-Weekly Exenatide on Clinical Outcomes in Patients With Preexisting Cardiovascular Disease
- (2019) Robert J. Mentz et al. CIRCULATION
- Exenatide once-weekly improves metabolic parameters, endothelial dysfunction and carotid intima-media thickness in patients with type-2 diabetes: An 8-month prospective study
- (2019) Angelo Maria Patti et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Exenatide twice-daily does not affect renal function or albuminuria compared to titrated insulin glargine in patients with type 2 diabetes mellitus: a post-hoc analysis of a 52-week randomised trial
- (2019) M.H.A. Muskiet et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Atherosclerotic cardiovascular disease and heart failure: Determinants of risk and outcomes in patients with diabetes
- (2019) Adam J. Nelson et al. PROGRESS IN CARDIOVASCULAR DISEASES
- Risk of heart failure hospitalization among users of dipeptidyl peptidase-4 inhibitors compared to glucagon-like peptide-1 receptor agonists
- (2018) Ghadeer K. Dawwas et al. Cardiovascular Diabetology
- Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1
- (2018) Daniel J. Drucker Cell Metabolism
- Impact of intravenous exenatide infusion for perioperative blood glucose control on myocardial ischemia-reperfusion injuries after coronary artery bypass graft surgery: sub study of the phase II/III ExSTRESS randomized trial
- (2018) Guillaume Besch et al. Cardiovascular Diabetology
- Cholesterol transport system: An integrated cholesterol transport model involved in atherosclerosis
- (2018) Xiao-Hua Yu et al. PROGRESS IN LIPID RESEARCH
- Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
- (2017) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Insulin Therapy Increases Cardiovascular Risk in Type 2 Diabetes
- (2017) Mary E. Herman et al. PROGRESS IN CARDIOVASCULAR DISEASES
- Effectiveness and safety of exenatide in Korean patients with type 2 diabetes inadequately controlled with oral hypoglycemic agents: an observational study in a real clinical practice
- (2017) You-Cheol Hwang et al. BMC Endocrine Disorders
- Serum total cholesterol and risk of cardiovascular and non-cardiovascular mortality in old age: a population-based study
- (2017) Yajun Liang et al. BMC Geriatrics
- Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: an 18-month prospective study
- (2016) Manfredi Rizzo et al. Cardiovascular Diabetology
- Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study
- (2016) Kamel Mohammedi et al. Cardiovascular Diabetology
- Carotid Intima-Media Thickness for Atherosclerosis
- (2016) Tomohisa Nezu et al. Journal of Atherosclerosis and Thrombosis
- The Use of Exenatide in Managing Markers of Cardiovascular Risk in Patients with Type 2 Diabetes: A Systematic Review
- (2016) Omorogieva Ojo International Journal of Environmental Research and Public Health
- Long-term changes in cardiovascular risk markers during administration of exenatide twice daily or glimepiride: results from the European exenatide study
- (2015) Rafael Simó et al. Cardiovascular Diabetology
- Profile of the Immune and Inflammatory Response in Individuals With Prediabetes and Type 2 Diabetes
- (2015) Vera Grossmann et al. DIABETES CARE
- Liraglutide decreases carotid intima-media thickness in patients with type 2 diabetes: 8-month prospective pilot study
- (2014) Manfredi Rizzo et al. Cardiovascular Diabetology
- Exenatide Twice Daily: A Review of Its Use in the Management of Patients with Type 2 Diabetes Mellitus
- (2014) Paul L. McCormack DRUGS
- Decreased carotid atherosclerotic process by control of daily acute glucose fluctuations in diabetic patients treated by DPP-IV inhibitors
- (2013) M. Barbieri et al. ATHEROSCLEROSIS
- Diagnosis and Classification of Diabetes Mellitus
- (2013) DIABETES CARE
- Exenatide improves endothelial function assessed by flow mediated dilation technique in subjects with type 2 diabetes: Results from an observational research
- (2012) Concetta Irace et al. Diabetes & Vascular Disease Research
- GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus
- (2012) Juris J. Meier Nature Reviews Endocrinology
- One-year treatment with exenatide vs. Insulin Glargine: Effects on postprandial glycemia, lipid profiles, and oxidative stress
- (2010) Mathijs C. Bunck et al. ATHEROSCLEROSIS
- Risk of Cardiovascular Disease Events in Patients With Type 2 Diabetes Prescribed the Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Exenatide Twice Daily or Other Glucose-Lowering Therapies: A retrospective analysis of the LifeLink database
- (2010) J. H. Best et al. DIABETES CARE
- Insulin use and increased risk of mortality in type 2 diabetes: a cohort study
- (2009) J.-M. Gamble et al. DIABETES OBESITY & METABOLISM
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More